Supernus Pharmaceuticals, Inc. (SUPN)

49.76 -0.13 (-0.26%) USD  |  NASDAQ  |  Dec 31, 14:00
More

Supernus Pharmaceuticals Net Non-Operating Interest Income Expense (Quarterly)

Net Non-Operating Interest Income Expense (Quarterly) Chart

View Net Non-Operating Interest Income Expense (Quarterly) for SUPN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Non-Operating Interest Income Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Non-Operating Interest Income Expense (Quarterly) Range, Past 5 Years

View Net Non-Operating Interest Income Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Non-Operating Interest Income Expense (Quarterly) Benchmarks

View Net Non-Operating Interest Income Expense (Quarterly) Benchmarks
Start Trial
BridgeBio Pharma, Inc. Upgrade
The Cooper Cos., Inc. Upgrade
Assembly Biosciences, Inc. Upgrade
Amphastar Pharmaceuticals, Inc. Upgrade
Viking Therapeutics, Inc. Upgrade